Best Compounds for Cognition: Evidence-Based Rankings
Cognitive enhancement has become an increasingly important health priority as people seek to optimize memory, attention, processing speed, and executive function throughout their lives. While lifestyle factors like sleep, exercise, and nutrition form the foundation of cognitive health, emerging research has identified specific compounds that demonstrate measurable improvements in brain function when supported by rigorous clinical evidence.
This comprehensive guide ranks the most evidence-supported compounds for cognitive enhancement, moving from the strongest scientific support to emerging options that show promise but require further investigation. Understanding the difference between preliminary findings and established efficacy helps you make informed decisions about cognitive supplementation.
Why Evidence-Based Ranking Matters
Not all cognitive compounds are created equal. Some rest on solid foundations of randomized controlled trials (RCTs) and meta-analyses involving hundreds of participants, while others rely on smaller studies or preliminary animal research. This ranking system uses a four-tier framework:
- Tier 4: Strong evidence from multiple RCTs and meta-analyses demonstrating consistent, clinically meaningful effects
- Tier 3: Probable efficacy with good supportive evidence but limited by sample sizes, inconsistent replication, or mixed results
- Tier 2: Preliminary evidence requiring further investigation
- Tier 1: Insufficient human evidence for reliable conclusions
Tier 4: Strong Evidence Compounds
Creatine Monohydrate (Supplement)
Creatine is an amino acid derivative that plays a central role in cellular energy production, particularly in the brain. It's one of the most researched supplements in existence, with decades of safety data in athletic and clinical populations.
Evidence Quality: Meta-analysis of 16 randomized controlled trials involving 492 participants demonstrates clinically meaningful improvements. Memory improved by a standardized mean difference (SMD) of 0.31 (95% CI: 0.18–0.44), while processing speed showed improvements with an SMD of -0.51 (95% CI: -1.01 to -0.01).
Key Findings: Effects are strongest in populations with lower baseline creatine levels, including older adults and vegetarians. The cognitive benefits appear consistent across independent research groups, making this one of the most reliable options for reproducible results.
Dosing: Standard supplementation involves a loading phase of 20g daily (divided into 4 doses) for 5-7 days, followed by 3-5g daily maintenance. Alternatively, 3g daily for 30 days produces similar results without loading.
Cost: Creatine monohydrate is exceptionally affordable, typically costing $0.05-0.15 per serving.
Ashwagandha (Supplement)
This traditional Ayurvedic herb contains withanolides, compounds that appear to support neuroplasticity and reduce cortisol-related cognitive decline. Unlike many herbal compounds, ashwagandha has generated substantial clinical research on cognition specifically.
Evidence Quality: Multiple well-designed randomized controlled trials with sample sizes ranging from 43 to 130 participants show consistent improvements across independent research groups. Results have been replicated in different populations, strengthening confidence in efficacy.
Key Findings: An 8-week randomized trial of 50 adults with mild cognitive impairment demonstrated statistically significant improvements on the Wechsler Memory Scale III, including logical memory I (p=0.007), verbal paired associates I (p=0.042), faces I (p=0.020), and family pictures I (p=0.006). Improvements span memory, attention, executive function, and reaction time.
Dosing: Effective doses range from 300-600mg daily of standardized extract (typically 4-5% withanolides) in divided doses.
Cost: Ashwagandha supplements typically cost $0.30-0.80 per serving.
Pycnogenol (Supplement)
Derived from French maritime pine bark, Pycnogenol is a flavonoid-rich extract with potent antioxidant and anti-inflammatory properties. It crosses the blood-brain barrier effectively and accumulates in neural tissue.
Evidence Quality: Multiple human randomized controlled trials and observational studies show consistent improvements, with effect sizes ranging from 7-30% on standardized cognitive measures.
Key Findings: A 12-week randomized controlled trial of 60 healthy professionals taking 150mg daily showed significant improvements in cognitive function, attention, and mental performance. Oxidative stress markers decreased by 30.4% in the treatment group compared to a +0.9% increase in controls (p<0.05). Evidence is strongest for attention, memory, and mental performance in both healthy aging and disease populations.
Dosing: Clinical studies typically use 150mg daily, often divided into two 75mg doses with meals for optimal absorption.
Cost: Pycnogenol is among the more expensive tier 4 options, ranging from $0.80-1.50 per serving.
L-Theanine (Amino Acid)
L-theanine is a non-protein amino acid found naturally in green tea that crosses the blood-brain barrier and interacts with GABAergic and dopaminergic systems. It's particularly effective when combined with caffeine, creating complementary effects on attention and focus.
Evidence Quality: Multiple well-designed human randomized controlled trials show consistent improvements, with effects most pronounced during cognitively demanding tasks or sleep-deprived states.
Key Findings: A study of 37 sleep-deprived adults using L-theanine combined with caffeine showed a statistically significant improvement in hit rate (P=0.02) and target-distractor discriminability (P=0.047). Reaction time improvement to targets was 38.1 milliseconds greater than placebo (P=0.003).
Dosing: Effective doses range from 100-200mg, typically combined with 40-100mg of caffeine. Effects emerge within 30-60 minutes of consumption.
Cost: L-theanine supplements cost approximately $0.10-0.30 per serving.
Tier 3: Probable Efficacy Compounds
Selank (Peptide)
Selank is a synthetic peptide derived from tuftsin, a natural immune-modulating peptide. It shows anxiolytic and potential cognitive-enhancing properties, though human evidence remains limited.
Evidence Quality: Based on 2 small randomized controlled trials and supporting animal studies. Evidence is limited by small sample sizes (n=40 and n=30) and lack of independent replication from research groups outside of originating laboratories.
Key Findings: In a combined treatment study, Selank plus phenazepam reduced benzodiazepine side effects including memory impairment, sedation, and fatigue compared to phenazepam monotherapy over a 4-week treatment course.
Dosing: Typical protocols use 250 mcg intranasal or intramuscular administration daily.
Cost: Selank remains relatively expensive due to limited commercial availability, typically $2-4 per dose.
Tesamorelin (Peptide)
Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog that may enhance cognitive function by increasing growth hormone and IGF-1 levels, which support neurogenesis and synaptic plasticity.
Evidence Quality: Two human randomized controlled trials demonstrate probable cognitive benefits in aging adults and those with mild cognitive impairment, but effect sizes are modest and long-term efficacy remains unproven. Results have not been independently replicated by other research groups.
Key Findings: A randomized controlled trial of 152 adults (66 with mild cognitive impairment, 76 healthy; ages 55-87) receiving 1mg daily for 20 weeks produced cognitive improvements, with results sustained 10 weeks after treatment cessation.
Dosing: Standard research protocols use 1mg daily via subcutaneous injection.
Cost: Tesamorelin is expensive and typically available only through prescription, costing $150-300 per month.
Humanin (Peptide)
Humanin is a cytoprotective peptide encoded within mitochondrial DNA that shows neuroprotective effects in animal models and human observational studies. It appears particularly relevant to cognitive aging and neuroinflammatory conditions.
Evidence Quality: Multiple human observational studies and consistent animal research support probable neuroprotective effects, but efficacy remains unproven in humans. Only 4 human randomized controlled trials exist, and none specifically measured cognitive outcomes in living subjects using validated cognitive assessments.
Key Findings: In a study of 268 humans with obstructive sleep apnea without dementia, neuron-derived exosome humanin levels were significantly elevated in the OSA+mild cognitive impairment group compared to OSA without mild cognitive impairment and control groups. Continuous positive airway pressure therapy reduced humanin levels after 1 year, correlating with cognitive improvement.
Dosing: Research protocols have varied; common dosing is 1-3 mg daily via injection.
Cost: Humanin remains primarily a research compound with limited commercial availability.
Cerebrolysin (Peptide)
Cerebrolysin is a standardized mixture of purified peptides and amino acids derived from porcine brain. It shows probable efficacy for cognitive improvement following stroke and in dementia populations.
Evidence Quality: Supported by multiple human studies and meta-analyses, but evidence is limited by small sample sizes, inconsistent effect measurements, and lack of independent replication in large-scale randomized controlled trials.
Key Findings: A meta-analysis of 6 randomized controlled trials with 597 participants with vascular dementia found the Mini-Mental State Examination improved by 1.10 points versus placebo (95% CI 0.37-1.82), while the Alzheimer's Disease Assessment Scale-Cognitive Plus improved by -4.01 points (95% CI -5.36 to -2.66).
Dosing: Clinical protocols typically use 10-30ml intravenous infusions daily for 10-20 consecutive days.
Cost: Cerebrolysin is expensive, typically costing $20-50 per infusion.
GLP-1 Receptor Agonists (Peptide)
GLP-1 receptor agonists, primarily developed for glucose regulation in diabetes, show promising neuroprotective effects on cognition through multiple mechanisms including neurogenesis, neuroinflammation reduction, and mitochondrial support.
Evidence Quality: Strong animal model evidence and preliminary human studies show some positive results in Alzheimer's disease and Parkinson's disease trials, but efficacy remains inconsistent and not yet conclusively proven in large, well-powered human randomized controlled trials.
Key Findings: A meta-analysis demonstrates that GLP-1 agonists increase neurogenesis in the dentate gyrus, hippocampus, olfactory bulb, and striatum across multiple animal models. Human trials are currently ongoing but results remain preliminary.
Dosing: Varies by specific agent; common protocols range from 0.5-2.4mg weekly for subcutaneous injection.
Cost: GLP-1 agonists cost $200-400 monthly, typically available only by prescription.
Cortexin (Peptide)
Cortexin is a neuropeptide complex extracted from porcine cortex containing small peptides that may support cognitive function through mechanisms including neurotrophic support and neuroprotection.
Evidence Quality: Shows probable efficacy across multiple human observational studies and one meta-analysis, with consistent improvements in attention, memory, and executive function. However, evidence is primarily from open-label observational designs rather than rigorous randomized controlled trials, and most high-quality studies originate from post-Soviet regions with limited independent replication.
Key Findings: In an open-label study of 52 participants with post-COVID cognitive impairment, treatment with 10mg intramuscular injection for 20 days improved concentration (p<0.05), executive function control (p<0.05), and auditory-verbal memory (p=0.002).
Dosing: Standard protocols use 10-20mg intramuscular injections for 10-20 consecutive days.
Cost: Cortexin typically costs $5-15 per injection.
Omega-3 Fatty Acids (Supplement)
Omega-3 polyunsaturated fatty acids, particularly docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), are essential structural and functional components of neuronal membranes that support synaptic plasticity and reduce neuroinflammation.
Evidence Quality: Show probable cognitive benefits in some populations, particularly older adults and those with cognitive decline, but efficacy is inconsistent across studies with modest effect sizes. Multiple human randomized controlled trials report null or mixed results, limiting conclusive claims.
Key Findings: A 24-month randomized controlled trial of cognitively healthy older adults (60 active versus 30 placebo) using combined omega-3 (430mg DHA, 90mg EPA), carotenoids, and vitamin E demonstrated working memory improvement with effect sizes of 0.090–0.105 (p significant).
Dosing: Effective cognitive doses typically range from 1-3g combined DHA+EPA daily.
Cost: Omega-3 supplements cost $0.20-0.60 per serving.
NAC (Supplement)
N-acetylcysteine (NAC) is a precursor to glutathione, the brain's primary antioxidant. It may support cognition through oxidative stress reduction and neuroprotection, with emerging evidence in specific psychiatric populations.
Evidence Quality: Shows probable efficacy for cognition in humans based on one randomized controlled trial demonstrating improved working memory in psychosis patients, plus emerging evidence from animal models of neuroprotection. However, evidence is limited to small human studies; large-scale, independent replication is lacking.
Key Findings: A 24-week randomized controlled trial of 58 psychosis patients found working memory improved significantly with NAC 2g daily versus placebo (Mann-Whitney U=98.5, p=0.027).
Dosing: Clinical protocols typically use 2-3g daily in divided doses.
Cost: NAC supplements cost approximately $0.15-0.40 per serving.
Zinc (Supplement)
Zinc is an essential micronutrient supporting synaptic plasticity, long-term potentiation, and neurotrophic signaling. Deficiency impairs cognition, and supplementation may restore function in at-risk populations.
Evidence Quality: Shows probable but inconsistent benefits for cognition in children and mixed results in adults. Human randomized controlled trials demonstrate modest improvements in specific cognitive domains, but effects are not universally significant and evidence remains limited by small sample sizes and heterogeneous outcomes.
Key Findings: A randomized controlled trial of 36 schoolchildren receiving 5mg daily for 3 months improved performance IQ on Picture Completion, Picture Arrangement, Block Design, and Object Assembly subtests (p=0.0001) but did not improve full-scale or verbal IQ.
Dosing: Cognitive support typically uses 10-30mg daily; excessive supplementation (>50mg daily long-term) can impair cognition.
Cost: Zinc supplements are inexpensive, typically $0.05-0.15 per serving.
Curcumin (Supplement)
Curcumin, the active compound in turmeric, shows potent anti-inflammatory and antioxidant properties with excellent blood-brain barrier penetration when combined with piperine or specialized delivery systems.
Evidence Quality: Shows probable efficacy for specific cognitive domains (working memory, processing speed) in older adults with adequate duration (≥24 weeks at ~0.8g daily), but global cognitive function improvements are inconsistent and efficacy has not been independently replicated in multiple high-quality randomized controlled trials.
Key Findings: A meta-analysis of 9 randomized controlled trials with 501 participants found curcumin significantly improved global cognitive function versus placebo (SMD=0.82, 95% CI 0.19-1.45, p=0.010) with an optimal dose of 0.8g daily.
Dosing: Effective protocols typically use 500mg-1g daily, preferably with piperine (5-10mg) for enhanced absorption, for durations of at least 24 weeks.
Cost: Curcumin supplements cost approximately $0.30-0.80 per serving.
Resveratrol (Supplement)
Resveratrol is a polyphenol found in grape skin that activates sirtuins and AMPK, supporting mitochondrial function and reducing neuroinflammation. It may be particularly relevant for age-related cognitive decline.
Evidence Quality: Demonstrates probable cognitive benefits in humans, particularly in postmenopausal women and Alzheimer's disease patients, but evidence remains limited by small sample sizes, short treatment durations, and mixed or null findings in several trials.
Key Findings: A meta-analysis of 3 randomized controlled trials with 166 total participants found delayed recognition improved with resveratrol versus placebo (SMD 0.39, 95% CI 0.08–0.70, p=0.01).
Dosing: Clinical trials typically use 150-500mg daily for 12-52 weeks.
Cost: Resveratrol supplements cost approximately $0.40-1.20 per serving.
How to Choose the Right Compound
Selecting an appropriate cognitive compound depends on several factors:
Start with Tier 4: Unless you have specific contraindications, compounds with tier 4 evidence (creatine, ashw